An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01715805
Recruitment Status : Completed
First Posted : October 29, 2012
Last Update Posted : March 12, 2018
Gedeon Richter Ltd.
Information provided by (Responsible Party):
Forest Laboratories

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : June 24, 2016
  Actual Study Completion Date : June 24, 2016